Ab Index-Nr. 607-029-00-3

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
607-029-00-3n-butyl propionate; [1]
sec-butyl propionate; [2]
iso-butyl propionate [3]
209-669-5 [1]
[2]
208-746-0 [3]
590-01-2 [1]
591-34-4 [2]
540-42-1 [3]
Flam. Liq. 3H226GHS02
Wng
H226  C
607-030-00-9propyl propionate203-389-7106-36-5Flam. Liq. 3
Acute Tox. 4 (*)
H226
H332
GHS02
GHS07
Wng
H226
H332
   
607-031-00-4butyl butyrate203-656-8109-21-7Flam. Liq. 3H226GHS02
Wng
H226  C
607-032-00-Xethyl acrylate205-438-8140-88-5Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317
 Skin Irrit. 2;
H315: C ≥ 5 %
Eye Irrit. 2; H319:
C ≥ 5%
STOT SE 3;
H335: C ≥ 5 %
D
607-033-00-5n-butyl methacrylate202-615-197-88-1Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317
  D
607-034-00-0methyl acrylate;
methyl propenoate
202-500-696-33-3Flam. Liq. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H332
H312
H302
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H332
H312
H302
H319
H335
H315
H317
  D
607-035-00-6methyl methacrylate;
methyl 2-methylprop-2-enoate;
methyl 2-methylpropenoate
201-297-180-62-6Flam. Liq. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H335
H315
H317
GHS02
GHS07
Dgr
H225
H335
H315
H317
  D
607-036-00-12-methoxyethyl acetate;
methylglycol acetate
203-772-9110-49-6Repr. 1B
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H360FD
H332
H312
H302
GHS08
GHS07
Dgr
H360FD
H332
H312
H302
   
607-037-00-72-ethoxyethyl acetate;
ethylglycol acetate
203-839-2111-15-9Flam. Liq. 3
Repr. 1B
Acute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
H226
H360FD
H332
H312
H302
GHS02
GHS08
GHS07
Dgr
H226
H360FD
H332
H312
H302
   
607-038-00-22-butoxyethyl acetate;
butylglycol acetate
203-933-3112-07-2Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
GHS07
Wng
H332
H312
   
607-039-00-82,4-D (ISO);
2,4-dichlorophenoxyacetic acid
202-361-194-75-7Acute Tox. 4 (*)
STOT SE 3
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 3
H302
H335
H318
H317
H412
GHS05
GHS07
Dgr
H302
H335
H318
H317
H412
   
607-040-00-3salts of 2,4-DAcute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
  A
607-041-00-92,4,5-T (ISO);
2,4,5-trichlorophenoxy acetic acid
202-273-393-76-5Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
   
607-042-00-4salts and esters of 2,4,5-T;
salts and esters of 2,4,5-trichlorophenoxy
acetic acid
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H335
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H335
H315
H410
  A
607-043-00-Xdicamba (ISO);
2,5-dichloro-6-methoxybenzoic acid;
3,6-dichloro-2-methoxybenzoic acid
217-635-61918-00-9Acute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 3
H302
H318
H412
GHS05
GHS07
Dgr
H302
H318
H412
   
607-044-00-53,6-dichloro-o-anisic acid, compound with
dimethylamine (1:1); [1]
potassium 3,6-dichloro-o-anisate [2]
218-951-7 [1]
233-002-7 [2]
2300-66-5 [1]
10007-85-9 [2]
Eye Irrit. 2
Aquatic Chronic 3
H319
H412
GHS07
Wng
H319
H412
   
607-045-00-0dichlorprop (ISO);
2-(2,4-dichlorophenoxy) propionic acid
204-390-5120-36-5Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
H312
H302
H315
H318
GHS05
GHS07
Dgr
H312
H302
H315
H318
   
607-046-00-6salts of dichlorpropAcute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H312
H302
GHS07
Wng
H332
H312
H302
  A
607-047-00-1fenoprop (ISO);
2-(2,4,5-trichlorophenoxy)pro-
pionic acid
202-271-293-72-1Acute Tox. 4 (*)
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H400
H410
GHS07
GHS09
Wng
H302
H315
H410
   
607-048-00-7salts of fenoprop;
salts of 2-(2,4,5-trichloro-
phenoxy)propionic acid
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
  A
607-049-00-2mecoprop (ISO);
2-(4-chloro-o-tolyloxy) propio-
nic acid;
(RS)-2-(4-chloro-o-tolyloxy)pro-
pionic acid; [1]
2-(4-chloro-2-methylphe-
noxy)propionic acid [2]
230-386-8 [1]
202-264-4 [2]
7085-19-0 [1]
708519-0 [2]
Acute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
 M = 100 
607-050-00-8salts of mecopropAcute Tox. 4 (*)
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
  A
607-051-00-3MCPA (ISO);
4-chloro-o-tolyloxyacetic acid
202-360-694-74-6Acute Tox. 4 *
Skin Irrit. 2
Eye Dam. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H315
H318
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H315
H318
H410
   
607-052-00-9salts and esters of MCPAAcute Tox. 4 *
Acute Tox. 4 *
Acute Tox. 4 *
Aquatic Acute 1
Aquatic Chronic 1
H332
H312
H302
H400
H410
GHS07
GHS09
Wng
H332
H312
H302
H410
  A
607-053-00-4MCPB (ISO);
4-(4-chloro-o-tolyloxy) butyric acid
202-365-394-81-5Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
607-054-00-Xsalts and esters of MCPBAcute Tox. 4 (*)H302GHS07
Wng
H302  A
607-055-00-5endothal-sodium (ISO);
disodium 7-oxabicy-
clo(2,2,1)heptane-2,3-
dicarboxylate
204-959-8129-67-9Acute Tox. 3 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H301
H312
H319
H335
H315
GHS06
Dgr
H301
H312
H319
H335
H315
   
bis 28.02.2018
607-056-00-0
warfarin (ISO); [1]
(S)-4-hydroxy-3-(3-oxo-1-
phenylbutyl)-2-benzopyrone; [2]
(R)-4-hydroxy-3-(3-oxo-1-
phenylbutyl)-2-benzopyrone [3]
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]
Repr. 1A
STOT RE 1
Aquatic Chronic 3
H360D
(*)(*)(*)
H372 (*)(*)
H412
GHS08
Dgr
H360D
(*)(*)(*)
H372 (*)(*)
H412
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
607-056-00-0
Warfarin (ISO);
4-Hydroxy-3-(3-oxo-1-
phenylbutyl)-2H-chromen-2-on; [1]
(S)-4-Hydroxy-3-(3-oxo-
1-phenylbutyl)-2-benzopyron; [2]
(R)-4-Hydroxy-3-(3-
oxo-1-phenylbutyl)-2-
benzopyron; [3]
201-377-6 [1]
226-907-3 [2]
226-908-9 [3]
81-81-2 [1]
5543-57-7 [2]
5543-58-8 [3]
Repr. 1A
Acut Tox. 1
Acut Tox. 1
Acut Tox. 2
STOT RE 1
Aquatic Chronic 2
H360D
H330
H310
H300
H372 (Blut)
H411
GHS08
GHS06
GHS09
Dgr
H360D
H330
H310
H300
H372 (Blut)
H411
 Repr. 1 A; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut):
C ≥ 0,5 %
STOT RE 2; H373 (Blut):
0,05 % ≤ C < 0,5 %
 
607-057-00-6coumachlor (ISO);
3-[1-(4-chlorophenyl)-3-oxo-
butyl]-4-hydroxycoumarin
201-378-181-82-3STOT RE 2 (*)
Aquatic Chronic 3
H373 (*)(*)
H412
GHS08
Wng
H373 (*)(*)
H412
   
607-058-00-1coumafuryl (ISO);
fumarin;
(RS)-3-(1-(2-furyl)-3-oxo-
butyl)4-hydroxycoumarin;
4-hydroxy-3-[3-oxo-1-(2-fu-
ryl) butyl]coumarin
204-195-5117-52-2Acute Tox. 3 (*)
STOT RE 1
Aquatic Chronic 3
H301
H372 (*)(*)
H412
GHS06
GHS08
Dgr
H301
H372 (*)(*)
H412
   
bis 28.02.2018
607-059-00-7
coumatetralyl;
4-hydroxy-3-(1,2,3,4-tetra-
hydro-1-naphthyl)coumarin
227-424-05836-29-3Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 1
Aquatic Chronic 3
H310
H300
H372 (*)(*)
H412
GHS06
GHS08
Dgr
H310
H300
H372 (*)(*)
H412
   
ab 01.03.2018*):
*) Die harmonisierten Einstufungen dürfen bereits vor dem genannten Datum verwendet werden.
607-059-00-7
Coumatetralyl (ISO);
4-Hydroxy-3-(1,2,3,4-tet-
rahydro-1-naphthyl)cu-
marin
227-424-05836-29-3Repr. 1B
Acute Tox. 2
Acute Tox. 3
Acute Tox. 2
STOT RE 1
Aquatic Chronic 1
H360D
H330
H311
H300
H372 (Blut)
H410
GHS08
GHS06
GHS09
Dgr
H360D
H330
H311
H300
H372 (Blut)
H410
 Repr. 1B; H360D:
C ≥ 0,003 %
STOT RE 1; H372 (Blut):
C ≥ 1,0 %
STOT RE 2; H373 (Blut)
0,1 % ≤ C < 1,0 %
M = 10
 
607-060-00-2dicoumarol;
4,4'-dihydroxy-3,3'-methylene-
bis(2H-chromen-2-one)
200-632-966-76-2STOT RE 1
Acute Tox. 4 (*)
Aquatic Chronic 2
H372 (*)(*)
H302
H411
GHS08
GHS07
GHS09
Dgr
H372 (*)(*)
H302
H411
   
607-061-00-8acrylic acid;
prop-2-enoic acid
201-177-979-10-7Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
Aquatic Acute 1
H226
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H332
H312
H302
H314
H400
 STOT SE 3;
H335: C ≥ 1 %
D
607-062-00-3n-butyl acrylate205-480-7141-32-2Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H226
H319
H335
H315
H317
GHS02
GHS07
Wng
H226
H319
H335
H315
H317
  D
607-063-00-9isobutyric acid201-195-779-31-2Acute Tox. 4 (*)
Acute Tox. 4 (*)
H312
H302
GHS07
Wng
H312
H302
   
607-064-00-4benzyl chloroformate207-925-0501-53-1Skin Corr. 1B
Aquatic Acute 1
Aquatic Chronic 1
H314
H400
H410
GHS05
GHS09
Dgr
H314
H410
 STOT SE 3;
H335: C ≥ 5 %
 
607-065-00-Xbromoacetic acid201-175-879-08-3Acute Tox. 3 *
Acute Tox. 3 *
Acute Tox. 3 *
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
H331
H311
H301
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H331
H311
H301
H314
H317
H400
   
607-066-00-5dichloroacetic acid201-207-079-43-6Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
   
607-067-00-0dichloroacetyl chloride201-199-979-36-7Skin Corr. 1A
Aquatic Acute 1
H314
H400
GHS05
GHS09
Dgr
H314
H400
   
607-068-00-6iodoacetic acid200-590-164-69-7Acute Tox. 3 (*)
Skin Corr. 1A
H301
H314
GHS06
GHS05
Dgr
H301
H314
   
607-069-00-1ethyl bromoacetate203-290-9105-36-2Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
H330
H310
H300
GHS06
Dgr
H330
H310
H300
   
607-070-00-7ethyl chloroacetate203-294-0105-39-5Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
H331
H311
H301
H400
GHS06
GHS09
Dgr
H331
H311
H301
H400
   
607-071-00-2ethyl methacrylate202-597-597-63-2Flam. Liq. 2
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H225
H319
H335
H315
H317
GHS02
GHS07
Dgr
H225
H319
H335
H315
H317
  D
607-072-00-82-hydroxyethyl acrylate212-454-9818-61-1Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
H311
H314
H317
H400
GHS06
GHS05
GHS09
Dgr
H311
H314
H317
H400
 (*)
Skin Sens. 1;
H317: C ≥ 0,2 %
D
607-073-00-34-CPA (ISO);
4-chlorophenoxyacetic acid
204-581-3122-88-3Acute Tox. 4 (*)H302GHS07
Wng
H302   
607-074-00-9chlorfenac(ISO);
2,3,6-trichlorophenylacetic acid
201-599-385-34-7Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-075-00-4chlorfenprop-methyl;
methyl 2-chloro-3-(4-chloro­phenyl)propionate
238-413-514437-17-3Acute Tox. 4 (*)
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H312
H302
H400
H410
GHS07
GHS09
Wng
H312
H302
H410
   
607-076-00-Xdodine(ISO);
dodecylguanidinium acetate
219-459-52439-10-3Acute Tox. 4 (*)
Eye Irrit. 2
Skin Irrit. 2
Aquatic Acute 1
Aquatic Chronic 1
H302
H319
H315
H400
H410
GHS07
GHS09
Wng
H302
H319
H315
H410
   
607-077-00-5erbon (ISO);
2-(2,4,5-trichlorophe-
noxy)ethyl 2,2-dichlo-
ropropionate
136-25-4Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-078-00-0fluenetil (ISO);
2-fluoroethyl biphenyl-4-ylacetate
4301-50-2Acute Tox. 1
Acute Tox. 2 (*)
H310
H300
GHS06
Dgr
H310
H300
   
607-079-00-6kelevan (ISO);
ethyl 5-(perchloro-5-
hydroxypentacy-
clo[5,3,0,02,6,03,9,04,8]de-
can-5-yl)-4-oxopentanoate;
ethyl 5-(1,2,3,5,6,7,8,9,10,10-
decachloro-4-hydroxypentacy-
clo(5,2,1,02,6,03,9,05,8)dec-4-
yl)-4-oxovalerate
4234-79-1Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Chronic 2
H311
H302
H411
GHS06
GHS09
Dgr
H311
H302
H411
   
607-080-00-1chloroacetyl chloride201-171-679-04-9Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 1
Skin Corr. 1A
Aquatic Acute 1
H331
H311
H301
H372 (*)(*)
H314
H400
GHS06
GHS08
GHS05
GHS09
Dgr
H331
H311
H301
H372 (*)(*)
H314
H400
EUH014
EUH029
  
607-081-00-7fluoroacetic acid205-631-7144-49-0Acute Tox. 2 (*)
Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400
   
607-082-00-2fluoroacetates, solubleAcute Tox. 2 (*)
Aquatic Acute 1
H300
H400
GHS06
GHS09
Dgr
H300
H400
  A
607-083-00-82,4-DB (ISO);
4-(2,4-dichlorophenoxy)butyric acid
202-366-994-82-6Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-084-00-3salts of 2,4-DBAcute Tox. 4 (*)
Eye Dam. 1
Aquatic Chronic 2
H302
H318
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H411
  A
607-085-00-9benzyl benzoate204-402-9120-51-4Acute Tox. 4 *
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
607-086-00-4diallyl phthalate205-016-3131-17-9Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
607-088-00-5methacrylic acid;
2-methylpropenoic acid
201-204-479-41-4Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
H312
H302
H314
GHS05
GHS07
Dgr
H312
H302
H314
 STOT SE 3;
H335: C ≥ 1 %
D
607-089-00-0propionic acid ... %201-176-379-09-4Skin Corr. 1BH314GHS05
Dgr
H314 Skin Corr. 1B;
H314: C ≥ 25 %
Skin Irrit. 2;
H319: 10 % ≤ C < 25 %
Eye Irrit. 2; H319:
10 % ≤ C < 25 %
STOT SE 3;
H335: C ≥ 10 %
B
607-090-00-6thioglycolic acid200-677-468-11-1Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
H331
H311
H301
H314
GHS06
GHS05
Dgr
H331
H311
H301
H314
 (*) 
607-091-00-1trifluoroacetic acid . . . %200-929-376-05-1Acute Tox. 4 (*)
Skin Corr. 1A
Aquatic Chronic 3
H332
H314
H412
GHS05
GHS07
Dgr
H332
H314
H412
 *B
607-092-00-7methyl lactate; [1]
methyl (±)-lactate; [2]
methyl (R)-lactate; [3]
methyl (S)-(-)-lactate [4]
208-930-0
[1]
218-449-8
[2]
241-420-6
[3]
248-704-9
[4]
547-64-8 [1]
2155-30-8 [2]
17392-83-5 [3]
27871-49-4 [4]
Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
H226
H319
H335
GHS02
GHS07
Wng
H226
H319
H335
  C
607-093-00-2propionyl chloride201-170-079-03-8Flam. Liq. 2
Skin Corr. 1B
H225
H314
GHS02
GHS05
Dgr
H225
H314
EUH014 BD
607-094-00-8peracetic acid . . . %201-186-879-21-0Flam. Liq. 3
Org. Perox. D
(*)(*)(*)(*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Corr. 1A
Aquatic Acute 1
H226
H242
H332
H312
H302
H314
H400
GHS02
GHS05
GHS07
GHS09
Dgr
H226
H242
H332
H312
H302
H314
H400
 (*)
STOT SE 3;
H335: C ≥ 1 %
BD
607-095-00-3maleic acid203-742-5110-16-7Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H302
H319
H335
H315
H317
GHS07
Wng
H302
H319
H335
H315
H317
 Skin Sens. 1;
H317: C ≥ 0,1 %
 
607-096-00-9maleic anhydride203-571-6108-31-6Acute Tox. 4 (*)
Skin Corr. 1B
Resp. Sens. 1
Skin Sens. 1
H302
H314
H334
H317
GHS08
GHS05
GHS07
Dgr
H302
H314
H334
H317
   
607-097-00-4benzene-1,2,4-tricarboxylic acid 1,2-anhydride;
trimellitic anhydride
209-008-0552-30-7STOT SE 3
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H335
H318
H334
H317
GHS08
GHS05
GHS07
Dgr
H335
H318
H334
H317
   
607-098-00-Xbenzene-1,2:4,5-tetra-
carboxylic dianhydride;
benzene-1,2:4,5-tetra-
carboxylic dianhydride;
pyromellitic dianhydride
201-898-989-32-7Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
   
607-099-00-51,2,3,6-tetrahydrophthalic anhydride; [1]
cis-1,2,3,6-tetrahydrophthalic anhydride; [2]
3,4,5,6-tetrahydrophthalic anhydride; [3]
tetrahydrophthalic anhydride [4]
201-605-4 [1]
213-308-7 [2]
219-374-3 [3]
247-570-9 [4]
85-43-8 [1]
935-79-5 [2]
2426-02-0 [3]
26266-63-7 [4]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
Aquatic Chronic 3
H318
H334
H317
H412
GHS08
GHS05
Dgr
H318
H334
H317
H412
  C
607-100-00-9benzophenone-3,3',4,4'-tetra-
carboxylic dianhydride;
4,4'-carbonyldi(phthalic anhydride)
219-348-12421-28-5Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335
 Eye Irrit. 2; H319:
C ≥ 1%
STOT SE 3;
H335: C ≥ 1 %
 
607-101-00-41,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicar-
boxylic anhydride chlorendic anhydride
204-077-3115-27-5Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H319
H335
H315
GHS07
Wng
H319
H335
H315
 Skin Irrit. 2;
H315: C ≥ 1 %
Eye Irrit. 2; H319:
C ≥ 1%
STOT SE 3;
H335: C ≥ 1 %
 
607-102-00-Xcyclohexane-1,2-dicarboxylic anhydride; [1]
cis-cyclohexane-1,2-dicar-
boxylic anhydride; [2]
trans-cyclohexane-1,2-dicarboxylic anhydride [3]
201-604-9
[1]
236-086-3
[2]
238-009-9
[3]
85-42-7 [1]
13149-00-3 [2]
14166-21-3 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
  C
607-103-00-5succinic anhydride203-570-0108-30-5Acute Tox. 4 *
Eye Irrit. 2
STOT SE 3
H302
H319
H335
GHS07
Wng
H302
H319
H335
 *
Eye Irrit. 2;
H319: C ≥ 1 %
STOT SE 3;
H335: C ≥ 1 %
 
607-104-00-0cyclopentane-1,2,3,4-tetra-
carboxylic dianhydride
227-964-76053-68-5Eye Irrit. 2
STOT SE 3
H319
H335
GHS07
Wng
H319
H335
 Eye Irrit. 2; H319:
C ≥ 1%
STOT SE 3;
H335: C ≥ 1 %
 
607-105-00-68,9,10-trinorborn-5-ene-2,3-
dicarboxylic anhydride; [1]
1,2,3,6-tetrahydro-3,6-metha-
nophthalic anhydride; [2]
(1α,2α,3β,6β)-1,2,3,6-tetra­hydro-3,6-metha­nophthalic anhydride [3]
204-957-7 [1]
212-557-9 [2]
220-384-5 [3]
129-64-6 [1]
826-62-0 [2]
2746-19-2 [3]
Eye Dam. 1
Resp. Sens. 1
Skin Sens. 1
H318
H334
H317
GHS08
GHS05
Dgr
H318
H334
H317
  C
607-106-00-18,9-dinorborn-5-ene-2,3-
dicarboxylic anhydride
123748-85-6Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Resp. Sens. 1
H302
H319
H335
H315
H334
GHS08
GHS07
Dgr
H302
H319
H335
H315
H334
 STOT SE 3;
H335: C ≥ 10 %
C
607-107-00-72-ethylhexyl acrylate203-080-7103-11-7STOT SE 3
Skin Irrit. 2
Skin Sens. 1
H335
H315
H317
GHS07
Wng
H335
H315
H317
  D
607-108-00-22-hydroxy-1-methylethylacry-
late; [1]
2-hydroxypropylacrylate; [2]
acrylic acid, monoester with propane-1,2-diol [3]
220-852-9 [1]
213-663-8 [2]
247-118-0 [3]
2918-23-2 [1]
999-61-1 [2]
25584-83-2 [3]
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317
 (*)
Skin Sens. 1;
H317: C ≥ 0,2 %
CD
607-109-00-8hexamethylene diacrylate;
hexane-1,6-diol diacrylate
235-921-913048-33-4Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
  D
607-110-00-3pentaerythritol triacrylate222-540-83524-68-3Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
  D
607-111-00-92,2-bis(acryloyloxymethyl)bu-
tyl acrylate;
trimethylolpropane triacrylate
239-701-315625-89-5Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
  D
607-112-00-42,2-dimethyltrimethylene diacrylate;
neopentyl glycol diacrylate
218-741-52223-82-7Acute Tox. 3 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317
 (*)D
607-113-00-Xisobutyl methacrylate202-613-097-86-9Flam. Liq. 3
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
Skin Sens. 1
Aquatic Acute 1
H226
H319
H335
H315
H317
H400
GHS02
GHS07
GHS09
Wng
H226
H319
H335
H315
H317
H400
  D
607-114-00-5ethylene dimethacrylate202-617-297-90-5STOT SE 3
Skin Sens. 1
H335
H317
GHS07
Wng
H335
H317
 STOT SE 3;
H335: C ≥ 10 %
D
607-115-00-0isobutyl acrylate203-417-8106-63-8Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
H226
H332
H312
H315
H317
GHS02
GHS07
Wng
H226
H332
H312
H315
H317
  D
607-116-00-6cyclohexyl acrylate221-319-33066-71-5STOT SE 3
Skin Irrit. 2
Aquatic Chronic 2
H335
H315
H411
GHS07
GHS09
Wng
H335
H315
H411
 STOT SE 3;
H335: C ≥ 10 %
D
607-117-00-12,3-epoxypropyl acrylate;
glycidyl acrylate
203-440-3106-90-1Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Corr. 1B
Skin Sens. 1
H331
H311
H301
H314
H317
GHS06
GHS05
Dgr
H331
H311
H301
H314
H317
 (*)
Skin Sens. 1;
H317: C ≥ 0,2 %
D
607-118-00-71-methyltrimethylene diacrylate;
1,3-butylene glycol diacrylate
243-105-919485-03-1Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317
  D
607-119-00-2tetramethylene diacrylate;
1,4-butyleneglycol diacrylate
213-979-61070-70-8Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
H312
H314
H317
GHS05
GHS07
Dgr
H312
H314
H317
  D
607-120-00-82,2'-oxydiethyl diacrylate;
diethylene glycol diacrylate
223-791-64074-88-8Acute Tox. 3 (*)
Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H311
H319
H315
H317
GHS06
Dgr
H311
H319
H315
H317
 (*)
Skin Sens. 1;
H317: C ≥ 0,2 %
D
607-121-00-38,9,10-trinorborn-2-yl acrylate10027-06-2Acute Tox. 4 (*)
Skin Irrit. 2
Skin Sens. 1
H312
H315
H317
GHS07
Wng
H312
H315
H317
  D
607-122-00-9pentaerythritol tetraacrylate225-644-14986-89-4Eye Irrit. 2
Skin Irrit. 2
Skin Sens. 1
H319
H315
H317
GHS07
Wng
H319
H315
H317
  D